JPRN-UMIN000006490招募中2 期
A phase II study of subcutaneous injection of bortezomib in combination with oral cyclophosphamide and dexamethasone (sVCD) for relapsed or refractory multiple myeloma - subcutaneous injection of bortezomib, oral cyclophosphamide and dexamethasone (sVCD) therapy for myeloma
Kyushu Hematology Organization for Treatment (KHOT)0 个研究点目标入组 31 人开始时间: 2011年10月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of allergic reactions to compounds containing mannitol, bortezomib, or boron. 2.Poorly controlled hypertension, diabetes mellitus, or other serious medical or psychiatric illness that could potentially interfere with the completion of treatment according to study protocol. 3.Active infection requiring treatment 4.Active hepatitis B or C. 5.Under treatment for a cancer other than multiple myeloma 6.Impaired kidney function requiring dialysis, liver function, cardiac function or pulmonary function. 7.Non-secretory myeloma, plasmacytoma, plasma cell leukemia, and POEMS syndrome. 8.Peripheral neuropathy > grade 2 9.Pregnant, lactation or potential
研究者
相似试验
进行中（未招募）
1 期
Treatment with daratumumab injections in moderate to severe ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 20.1Level: LLTClassification code 10028414Term: Myalgic encephalomyelitisSystem Organ Class: 100000004862EUCTR2022-000281-18-NOHaukeland University Hospital, Dept. of Oncology and Medical Physics10
进行中（未招募）
1 期
Daratumumab in ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 26.1Level: LLTClassification code: 10028414Term: Myalgic encephalomyelitis Class: 10021881CTIS2024-512500-19-00Helse Bergen HF10
已完成
2 期
Phase II study of induction therapy with subcutaneous bortezomib, oral melphalan and predonisone for newly diagnosed multiple myeloma patients ineligible for stem cell transplantatioMultiple MyelomaJPRN-UMIN000010401Kanagawa Clinical Oncology Group37
进行中（未招募）
1 期
The effect of subcutaneous injection of Botulinum Toxin A on chronic wound pain in lower extremities, a prospective exploratory studychronic wound pain and wound healingMedDRA version: 20.1Level: LLTClassification code 10049542Term: Wound painSystem Organ Class: 100000004863EUCTR2021-000096-36-DKDepartment of Dermatology and Copenhagen Wound Healing Center, Bispebjerg Hospital16
招募中
不适用
A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumorGastric mesenchymal tumorJPRN-UMIN000045414Osaka International Cancer Institute22